SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$20.39
-0.14 (-0.68%)
▼
5d:
+0.34%
30d:
-7.44%
90d:
-1.55%
BUY
HIGH Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SBRA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SBRA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.09
Based on 10.0% avg growth
INTRINSIC VALUE TODAY
$19.30
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $20.39, which is considered slightly low relative to its 30-day fair value range of $19.96 to $21.67. The stock's valuation (Forward PE: 26.2) is in line with its historical norms (26.0). At these levels, the market is pricing in 0.2% annual earnings growth.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is approaching resistance at $20.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBRA scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $22.57 (+11.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is approaching resistance at $20.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBRA scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $22.57 (+11.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$19.96 -
$21.67
Company Quality Score
70/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
91.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($22.57)
- BULLISH: Expecting earnings turnaround to 0.2% growth with 25.3% revenue growth
- BULLISH: Bottoming setup score 72/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$19.96 -
$21.67
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$19.71
Resistance Level
$20.88
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.17
Wall Street Target
$22.57
(+11.0%)
Revenue Growth (YoY)
25.3%
Earnings Growth (YoY)
-5.6%
Profit Margin
7.6%
Valuation Premium vs History
+0.2% premium
PE vs Historical
26.2 vs 26.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$20.37
(+0%)
2-Year Target
$20.41
(+0%)
3-Year Target
$20.45
(+1%)
3-Yr Target (if PE normalizes)
(PE: 26→26)
PE COMPRESSION
$20.32
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.2, Growth: 15.9%)
$31.67
(+56%)
Base:
(SPY PE: 20.1, Growth: 15.9%)
$24.33
(+20%)
Bear:
(PE: 17.1, Growth: 15.9%)
$20.68
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Forward PE: 32.15 | Forward EPS (Implied): $0.63
Bull Case
$24.62
(+21%)
Analyst growth 15.0%, PE expands to 33.8
Base Case
$20.39
(0%)
Market implied 0.0%, PE stable at 32.2
Bear Case
$15.60
(-24%)
Severe decline -15.0%, PE contracts to 28.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$100 | 66 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$256 | 63 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$23 | 53 HOLD |
|
OHI
Omega Healthcare Investo… |
HOLD
16 analysts |
$52 | 77 BUY |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$16 | 64 BUY |
